All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0711 | Anti-G6PD (CBFYH-0209) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0209 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0714 | Anti-G6PD (CBFYH-0210) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0210 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0816 | Anti-G6PD (AT2F6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | AT2F6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0817 | Anti-G6PD (CBFYH-0208) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0208 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3964 | Anti-G6PD (CBFYH-0209) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0209 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3967 | Anti-G6PD (CBFYH-0210) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0210 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4069 | Anti-G6PD (AT2F6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | AT2F6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4070 | Anti-G6PD (CBFYH-0208) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0208 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1011 | Anti-G6PD (D5D2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Monkey | D5D2 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1012 | Anti-G6PD (CBLG1-2498) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Human | CBLG1-2498 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2651 | Anti-G6PD(D5D2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Monkey | D5D2 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2652 | Anti-G6PD(CBLG1-2498) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Human | CBLG1-2498 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION